Journal Article Summary
The article examines the effects of metformin, a medication primarily used to treat type 2 diabetes, on various health conditions, including cancer, neurodegenerative diseases, and COVID-19. Researchers are particularly interested in how metformin interacts with a protein called VDAC1, which plays a crucial role in cell metabolism and death. Understanding metformin's broader implications beyond diabetes is important, as it may offer insights into its potential benefits and risks in treating other diseases.
The authors reviewed existing studies and literature to analyze metformin's mechanisms of action and its effects on different diseases. They found that metformin can have both beneficial and adverse effects, depending on the condition being treated. For instance, while it may promote cell death in cancer cells, it can protect against cell death in neurodegenerative diseases. The involvement of VDAC1 appears to be a common factor in these opposing effects, suggesting that it could be a key target for metformin's diverse actions.
Despite its potential benefits, the article highlights several limitations and concerns regarding metformin use. There are conflicting findings about its effects on cognitive function and aging, with some studies suggesting it may increase the risk of cognitive decline. Patients should discuss any concerns about metformin with their healthcare providers, particularly regarding its side effects, such as gastrointestinal issues and vitamin B12 deficiency, as well as its role in managing conditions like diabetes and COVID-19.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Shoshan-Barmatz Varda, Anand Uttpal, Nahon-Crystal Edna, Di Carlo Marta, Shteinfer-Kuzmine Anna. Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?. Frontiers in Physiology 2021. DOI: 10.3389/fphys.2021.730048. PMID: 34671273. PMCID: PMC8521008.
Featured Pill Pals Product
Metformin 500 mg Immediate Release Tablets --- Ascend Pharma --- Generic for Glucophage
Metformin 500 mg Immediate Release Tablets — Ascend Pharma — Generic for Glucophage is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
